JAMA Oncology : Hyperprogressive Disease in Patients With Advanced NSCLC Treated With PD-1/PD-L1 Inhibitors
Interview with Benjamin Besse, MD, author of Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - September 6, 2018 Category: General Medicine Source Type: podcasts
Goals for precision medicine in NSCLC
Silvia Novello, MD, PhD, of San Luigi Gonzaga University Hospital, Orbassano, Italy, discusses precision medicine at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland. She exp...
Author: VJOncology
Added: 09/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 4, 2018 Category: Cancer & Oncology Source Type: podcasts
The reality of implementing TKI therapies for NSCLC in Europe
Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Silvia Novello, MD, PhD, of San Luigi Gonzaga University Hospital, Orbassano, Italy, discusses the logistical ...
Author: VJOncology
Added: 08/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 31, 2018 Category: Cancer & Oncology Source Type: podcasts
Therapy sequencing in the current NSCLC treatment landscape
In this video, recorded at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Nicolas Girard, MD, PhD, of Claude Bernard University, Lyon, France, discusses treatment sequenci...
Author: VJOncology
Added: 08/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 31, 2018 Category: Cancer & Oncology Source Type: podcasts
Optimizing treatment of ALK+ NSCLC: clinical realities
In this video, recorded at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Silvia Novello, MD, PhD, of San Luigi Gonzaga University Hospital, Orbassano, Italy, discusses ho...
Author: VJOncology
Added: 08/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 31, 2018 Category: Cancer & Oncology Source Type: podcasts
Impact of new TKIs on NSCLC treatment planning
Several generations of tyrosine kinase inhibitors (TKIs) have now been produced and examined for the treatment of EGFR mutant non-small cell lung cancer (NSCLC). Here, Nicolas Girard, MD, PhD, of Clau...
Author: VJOncology
Added: 08/31/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 31, 2018 Category: Cancer & Oncology Source Type: podcasts
The need for RCTs in immunotherapy for mesothelioma
Speaking from the 2018 European Lung Cancer Congress (ELCC) in Geneva, Switzerland, Dean Fennell, PhD, FRCP, of the University of Leicester, Leicester, UK, stresses the need for increased randomized c...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Lung cancer today: screening, surgery & amp; radiotherapy
Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Matti Aapro, MD, of the Clinique de Genolier, Genolier, Switzerland, discusses the hot topics in lung cancer t...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Lung cancer treatment: where are we now?
New lung cancer therapies are constantly being developed and approved. Indeed, the new treatments on the market have rendered chemotherapy increasingly redundant. Matti Aapro, MD, of the Clinique de G...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Increasing cigarette price as a lung cancer prevention incentive
Decreasing tobacco intake is a key goal for reducing the incidence of lung cancer. In this video, recorded at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Matti Aapro, M...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Lung cancer screening: where are we now?
Lung cancer screening is an exciting and debated topic. Here, Mamta Ruparel, MBBS, MRCP, of University College London, London, UK, discusses the current data and logistical considerations associated w...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Establishing guidelines for categorizing nodules in lung cancer screening
Mamta Ruparel, MBBS, MRCP, of University College London, London, UK, discusses the current data and guidelines associated with the finding of pulmonary nodules in lung cancer screening. She explains t...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy in NSCLC: a perspective
Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Giorgio Scagliotti, MD, PhD, from the University of Turin, Turin, Italy, provides an overview of recent trial ...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Increased survival in NSCLC: new considerations
Speaking from the 2018 European Lung Cancer Congress (ELCC) in Geneva, Switzerland, Federico Capuzzo, MD, PhD, of AUSL della Romagna, Ravenna, Italy, talks about how overall survival has improved in p...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Novel therapies for the treatment of NSCLC: immunotherapy and targeted agents
In this interview, Federico Capuzzo, MD, PhD, of AUSL della Romagna, Ravenna, Italy, discusses novel therapies for the treatment of non-small cell lung cancer (NSCLC) from the 2018 European Lung Cance...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts